DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.
Source | Last Updated |
---|---|
DisGeNET | July 29, 2024 |
Disease ID | Disease Name | Gene Symbol | Gene ID | Gene Name ▲ | UniProt ID |
---|---|---|---|---|---|
C0022661 | Kidney Failure, Chronic | GALNT3 | 2591 | polypeptide N-acetylgalactosaminyltransferase 3 | Q14435 |
C0699790 | Colon Carcinoma | GALNT4 | 8693 | polypeptide N-acetylgalactosaminyltransferase 4 | Q8N4A0 |
C0010068 | Coronary heart disease | GALNT4 | 8693 | polypeptide N-acetylgalactosaminyltransferase 4 | Q8N4A0 |
C1956346 | Coronary Artery Disease | GALNT4 | 8693 | polypeptide N-acetylgalactosaminyltransferase 4 | Q8N4A0 |
C0007102 | Malignant tumor of colon | GALNT4 | 8693 | polypeptide N-acetylgalactosaminyltransferase 4 | Q8N4A0 |
C0006142 | Malignant neoplasm of breast | GALNT4 | 8693 | polypeptide N-acetylgalactosaminyltransferase 4 | Q8N4A0 |
C0376358 | Malignant neoplasm of prostate | GALNT4 | 8693 | polypeptide N-acetylgalactosaminyltransferase 4 | Q8N4A0 |
C0027651 | Neoplasms | GALNT4 | 8693 | polypeptide N-acetylgalactosaminyltransferase 4 | Q8N4A0 |
C0742343 | Acute Chest Syndrome | GALNT4 | 8693 | polypeptide N-acetylgalactosaminyltransferase 4 | Q8N4A0 |
C0006142 | Malignant neoplasm of breast | GALNT5 | 11227 | polypeptide N-acetylgalactosaminyltransferase 5 | Q7Z7M9 |
C0006826 | Malignant Neoplasms | GALNT5 | 11227 | polypeptide N-acetylgalactosaminyltransferase 5 | Q7Z7M9 |
C0027651 | Neoplasms | GALNT5 | 11227 | polypeptide N-acetylgalactosaminyltransferase 5 | Q7Z7M9 |
C0699791 | Stomach Carcinoma | GALNT5 | 11227 | polypeptide N-acetylgalactosaminyltransferase 5 | Q7Z7M9 |
C0235974 | Pancreatic carcinoma | GALNT5 | 11227 | polypeptide N-acetylgalactosaminyltransferase 5 | Q7Z7M9 |
C1335302 | Pancreatic Ductal Adenocarcinoma | GALNT5 | 11227 | polypeptide N-acetylgalactosaminyltransferase 5 | Q7Z7M9 |
C1306459 | Primary malignant neoplasm | GALNT5 | 11227 | polypeptide N-acetylgalactosaminyltransferase 5 | Q7Z7M9 |
C0024623 | Malignant neoplasm of stomach | GALNT5 | 11227 | polypeptide N-acetylgalactosaminyltransferase 5 | Q7Z7M9 |
C0006826 | Malignant Neoplasms | GALNT6 | 11226 | polypeptide N-acetylgalactosaminyltransferase 6 | Q8NCL4 |
C1306459 | Primary malignant neoplasm | GALNT6 | 11226 | polypeptide N-acetylgalactosaminyltransferase 6 | Q8NCL4 |
C0699790 | Colon Carcinoma | GALNT6 | 11226 | polypeptide N-acetylgalactosaminyltransferase 6 | Q8NCL4 |
C0009402 | Colorectal Carcinoma | GALNT6 | 11226 | polypeptide N-acetylgalactosaminyltransferase 6 | Q8NCL4 |
C0206701 | Cystadenocarcinoma, Serous | GALNT6 | 11226 | polypeptide N-acetylgalactosaminyltransferase 6 | Q8NCL4 |
C0678222 | Breast Carcinoma | GALNT6 | 11226 | polypeptide N-acetylgalactosaminyltransferase 6 | Q8NCL4 |
C0476089 | Endometrial Carcinoma | GALNT6 | 11226 | polypeptide N-acetylgalactosaminyltransferase 6 | Q8NCL4 |
C1140680 | Malignant neoplasm of ovary | GALNT6 | 11226 | polypeptide N-acetylgalactosaminyltransferase 6 | Q8NCL4 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024